Hanrahan Jessie 4
4 · Solid Biosciences Inc. · Filed Dec 4, 2025
Insider Transaction Report
Form 4
Hanrahan Jessie
Chief Regulatory Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-02+11,862→ 31,143 total - Sale
Common Stock
2025-12-03$5.11/sh−4,483$22,908→ 26,660 total - Exercise/Conversion
Restricted Stock Units
2025-12-02−11,862→ 11,863 total→ Common Stock (11,862 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").
- [F2]This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Dr. Hanrahan on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Hanrahan.
- [F3]The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.